Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 2 (5-HT2) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D1 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Muscarinic acetylcholine receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | 5-hydroxytryptamine receptor 1, putative | Get druggable targets OG5_132667 | All targets in OG5_132667 |
Schistosoma japonicum | 5-hydroxytryptamine receptor, putative | Get druggable targets OG5_132667 | All targets in OG5_132667 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.1198 | 0.3623 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.1198 | 0.3623 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1198 | 0.3623 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1198 | 0.3623 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0608 | 0.0107 | 0.0294 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.1198 | 0.3623 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.1198 | 0.3623 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
-Log Ki (binding) | = 5.86 | Binding affinity against muscarinic (M) receptor | ChEMBL. | 7907148 |
-Log Ki (binding) | = 5.97 | Binding affinity against dopamine receptor D1 | ChEMBL. | 7907148 |
-Log Ki (binding) | = 6.44 | Binding affinity against dopamine D2 receptor | ChEMBL. | 7907148 |
-Log Ki (binding) | = 7.35 | Binding affinity against serotonin 5-hydroxytryptamine 2 receptor | ChEMBL. | 7907148 |
Inhibition (functional) | = 100 % | Inhibitory activity in apomorphine antagonism test at a dose of 20mg/kg,sc | ChEMBL. | 7907148 |
Ki (binding) | = 5.86 | Binding affinity against muscarinic (M) receptor | ChEMBL. | 7907148 |
Ki (binding) | = 5.97 | Binding affinity against dopamine receptor D1 | ChEMBL. | 7907148 |
Ki (binding) | = 6.44 | Binding affinity against dopamine D2 receptor | ChEMBL. | 7907148 |
Ki (binding) | = 7.35 | Binding affinity against serotonin 5-hydroxytryptamine 2 receptor | ChEMBL. | 7907148 |
Ratio (binding) | = 1.08 | Ratio of binding affinity towards D2 to D1 receptor was measured | ChEMBL. | 7907148 |
Ratio (binding) | = 1.1 | Ratio of binding affinity towards D2 to muscarinic receptor (M) was measured | ChEMBL. | 7907148 |
Ratio (binding) | = 1.14 | Ratio of binding affinity towards 5-HT2 to D2 receptor was measured | ChEMBL. | 7907148 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.